You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

primary HCC

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Hepatocellular Carcinoma Trial in Guangzhou (drug, procedure, radiation)

Not yet recruiting
  • Advanced Hepatocellular Carcinoma
  • Guangzhou, Guangdong, China
    The First Affiliated Hospital of Sun Yat-sen University
Feb 7, 2023

Hepatocellular Carcinoma Trial in Yichang (Sintilimab)

Recruiting
  • Hepatocellular Carcinoma
  • Yichang, Hubei, China
    Department of Medical Oncology, Central Hospital of Yichang City
Sep 1, 2023

Hepatocellular Carcinoma Trial (Donafenib + Tislelizumab)

Not yet recruiting
  • Hepatocellular Carcinoma
  • Donafenib + Tislelizumab
  • (no location specified)
Sep 15, 2022

Hepatocellular Carcinoma Trial in Taipei City, Taipei (Para-Toluenesulfonamide)

Recruiting
  • Hepatocellular Carcinoma
  • Taipei City, Taiwan
  • +2 more
Mar 28, 2022

Primary Liver Cancer, Radiofrequency Ablation, Immunotherapy Trial in Guangzhou (Neo-MASCT)

Recruiting
  • Primary Liver Cancer
  • +3 more
  • Neo-MASCT
  • Guangzhou, Guangdong, China
    The First Affiliated Hospital of Sun Yat-sen University
Jan 10, 2022

Advanced Hepatocellular Carcinoma (HCC), Gastric Cancer Metastatic to Liver, Colorectal Cancer Metastatic to Liver Trial in

Recruiting
  • Advanced Hepatocellular Carcinoma (HCC)
  • +2 more
  • Duarte, California
  • +2 more
Aug 29, 2022

Hepatocellular Carcinoma (HCC) Trial in Beijing (Expanded Activated Lymphocytes (EAL), transarterial chemoembolization (TACE))

Recruiting
  • Hepatocellular Carcinoma (HCC)
  • Expanded Activated Lymphocytes (EAL)
  • transarterial chemoembolization (TACE)
  • Beijing, Beijing, China
    Chinese PLA General Hospital
Feb 4, 2022

Liver Tumor, HCC, Metastasis Trial in Worldwide (HistoSonics Histotripsy)

Recruiting
  • Liver Tumor
  • +2 more
  • HistoSonics Histotripsy
  • Braunschweig, Germany
  • +5 more
Oct 13, 2022

Liver Tumor, HCC, Metastasis Trial in United States (HistoSonics Histotripsy)

Recruiting
  • Liver Tumor
  • +2 more
  • HistoSonics Histotripsy
  • Miami, Florida
  • +7 more
Jan 3, 2023

Liver Cancer, Liver Cirrhosis, Hepatocellular Carcinoma Trial in Saudi Arabia, Vietnam (GALAD Score)

Active, not recruiting
  • Liver Cancer
  • +3 more
  • GALAD Score
  • Jeddah, Saudi Arabia
  • +9 more
May 11, 2022

Optimizing Y90 Therapy for Radiation Lobectomy

Recruiting
  • HCC
  • +4 more
  • Y90 radioembolization
  • Chicago, Illinois
    Northwestern University
Aug 27, 2021

HCC Trial in Leiden (Additional intraprocedural pre-ablation CT-scan)

Completed
  • HCC
  • Additional intraprocedural pre-ablation CT-scan
  • Leiden, Zuid-Holland, Netherlands
    Leiden University Medical Center
Aug 30, 2021

Adult Primary Hepatocellular Carcinoma, Localized Resectable Adult Primary Liver Cancer, Localized Unresectable Adult Primary

Suspended
  • Adult Primary Hepatocellular Carcinoma
  • +3 more
  • sorafenib tosylate
  • +2 more
  • Birmingham, Alabama
  • +20 more
Aug 29, 2022

Patients Eligible to a Curative Treatment for Primary HCC Trial in La Tronche, Lyon, Pierre-Bénite (PET/MRI system (SIEMENS AG,

Recruiting
  • Patients Eligible to a Curative Treatment for Primary HCC
  • PET/MRI system (SIEMENS AG, Munich, Germany; distributed in France by SIEMENS S.A.S, Saint-Denis, France)
  • La Tronche, France
  • +3 more
Jan 12, 2021

Detect and Expunge Concealed Tumors of the Liver

Recruiting
  • Liver Cancer
    • Hanoi, Vietnam
      108 Military Central Hospital
    Nov 15, 2023

    circRNAs (hsa_circ_0004001) in Early Diagnosis of HCC

    Not yet recruiting
    • Hepatic Cell Carcinoma
      • (no location specified)
      Sep 12, 2023

      Liver Cancer Risk Computation (LIRIC) Models

      Active, not recruiting
      • Predictive Cancer Model
      • Liver Risk Computation Model (LIRIC)
      • +2 more
      • Boston, Massachusetts
        Beth Israel Deaconess Medical Center
      Nov 21, 2023

      Cirrhotic Patients With and Without Hepatocellular Carcinoma

      Not yet recruiting
      • Pulmonary Complications of Liver Cirrhosis and HCC
      • spirometry
      • Sohag, Egypt
        Sohag University hospitals
      Jul 26, 2023

      Novel Biomarker Assay for Biomarker Assay for HCC Detection

      Not yet recruiting
      • Hepato-cellular Carcinoma
        • (no location specified)
        Aug 8, 2022

        Long Non-coding RNA SNHG15 asNovel Biomarker in HBV Associated

        Not yet recruiting
        • HCC
        • No intervention was required for patients or control group in this study
        • (no location specified)
        Apr 21, 2023

        HepaSphere Drug-eluting Bead Transarterial Chemoembolization

        Recruiting
        • Advanced Hepatocellular Carcinoma (HCC)
        • DEB-TACE plus HAIC or HAIC alone
        • Beijing, Beijing, China
          Beijing Cancer Hospital
        May 19, 2023

        HCC Trial in Hong Kong (Zabadinostat (CXD101) and Geptanolimab, Lenvatinib and Sorafenib)

        Not yet recruiting
        • HCC
        • Zabadinostat (CXD101) and Geptanolimab
        • Lenvatinib and Sorafenib
        • Hong Kong, Hong Kong
          Department of Clinical Oncology, Prince of Wales Hospital
        May 15, 2023

        Hepatocellular Carcinoma Resectable Trial in Fuzhou (neoadjuvant therapy)

        Not yet recruiting
        • Hepatocellular Carcinoma Resectable
        • neoadjuvant therapy
        • Fuzhou, Fujian, China
          The First Affiliated Hospital of Fujian Medical University
        Aug 19, 2023

        Cirrhosis, Liver Trial (Epigallocatechin gallate (EGCG), Placebo)

        Not yet recruiting
        • Cirrhosis, Liver
        • Epigallocatechin gallate (EGCG)
        • Placebo
        • (no location specified)
        Aug 27, 2023

        Hepatocellular Carcinoma Trial in Hangzhou (Anlotinib Hydrochloride)

        Terminated
        • Hepatocellular Carcinoma
        • Anlotinib Hydrochloride
        • Hangzhou, Zhejiang, China
          The First Affiliated Hospital of Medical School of Zhejiang Univ
        Aug 25, 2022